Shortage of lidocaine with epinephrine: Causes and solutions - 16/07/18
Doi : 10.1016/j.jaad.2018.02.035
Brandon Bodie, BS a, ⁎ 
, Robert T. Brodell, MD b, Stephen E. Helms, MD b
, Robert T. Brodell, MD b, Stephen E. Helms, MD b a University of Alabama at Birmingham, Birmingham, Alabama
b Department of Dermatology, University of Mississippi Medical Center, Jackson, Mississippi
∗Reprint requests: Brandon Bodie, BS, 401 19th St S, Apt 204, Birmingham, AL 35233.401 19th St S, Apt 204BirminghamAL35233
Key words : lidocaine with epinephrine, local anesthetics, shortage of lidocaine with epinephrine, shortage of local anesthetics, shortage of Xylocaine with epinephrine, Xylocaine with epinephrine
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Conflicts of interest: Dr Brodell participated in multicenter clinical trials for Galderma Laboratories LP, Novartis, and Glaxo Smith Kline. He serves on the editorial boards of American Medical Student Research Journal, Practice Update Dermatology, Practical Dermatology, Journal of the Mississippi State Medical Society, and SKIN: The Journal of Cutaneous Medicine. Other authors have no conflicts of interest to disclose. |
© 2018
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 79 - N° 2
P. 392-393 - août 2018 Retour au numéro
Article précédent
- Real-world evidence–What is it and does it matter for approval of drugs?
- William H. Eaglstein
- The “dermatologist recommended” label: Is it meaningful?
- Mary E. Lohman, Peter A. Lio, Shuai Xu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?